Keryx says anemia drug succeeds in study of kidney patients

(Reuters) - Keryx Biopharmaceuticals Inc on Tuesday said its drug to treat iron deficiency anemia in chronic kidney disease patients not yet requiring dialysis met the goals of a late stage clinical trial, potentially paving the way for an expanded approval of the treatment.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro